Karl Van Tassel (1925) Career Development Professor
Researchers including Assistant Professor Giovanni Traverso have designed a new face mask that could stop viral particles as effectively as N95 masks. and can be easily sterilized and used many times.
A team of researchers including Assistant Professor Giovanni Traverso developed a kirigami-inspired stent system that can support the rapid delivery of drugs to long tubular organs like the gastrointestinal tract.
A team of researchers including Assistant Professor Giovanni Traverso have developed an ingestible capsule capable of delivering antibodies, insulin and other drugs which usually require an injection.
Trinity College, University of Cambridge
B.A.Johns Hopkins University
Ph.D.Trinity College, University of Cambridge
M.B., B.Chir.Ingestible and implantable robotics
Biocompatible smart materials
Translational science
Drug delivery for optimal drug adherence
Biomedical device development
Early detection of cancer
“Inactive ingredients” and their potential benefits and harms
Prof. Giovanni Traverso is the Director of the Laboratory for Translational Engineering (www.l4te.org), Associate Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT), a gastroenterologist in the Division of Gastroenterology, Brigham and Women’s Hospital (BWH), Harvard Medical School and an Associate Member of the Broad Institute. Dr. Traverso grew up in Peru, Canada and the United Kingdom. He received his BA from Trinity College, University of Cambridge, UK, and his PhD from the lab of Prof. Bert Vogelstein at Johns Hopkins University. He subsequently completed medical school at the University of Cambridge, internal medicine residency at the Brigham and Women’s Hospital and his gastroenterology fellowship training at Massachusetts General Hospital, both at Harvard Medical School. Dr. Traverso’s previous work focused on the development of novel molecular tests for the early detection of colon cancer. For his post-doctoral research, he transitioned to the fields of chemical and biomedical engineering in the laboratory of Professor Robert Langer at MIT where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.
His current research program is focused on developing the next generation of drug delivery systems to enable safe and efficient delivery of therapeutics, biomedical device to support new modes of drug administration and sensing a broad array of physiologic and pathophysiologic signals. Additionally, Dr. Traverso continues his efforts towards the development of novel diagnostic tests that enable the early detection of cancer.
LinkedIn: https://www.linkedin.com/in/giovanni-traverso-84386742/
Google Scholar: https://scholar.google.com/citations?user=Htybq6sAAAAJ&hl=en
PubMed – My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/carlo.traverso.1/bibliography/public/
2002 Collegiate Inventors Competition
2002 Research Fellowship, Trinity College, University of Cambridge
2003 MIT TR100
2016 Inventions Award, Popular Science
2022 Fellow, Controlled Release Society College of Fellows
2023 Fellow, National Academy of Inventors
2024 Fellow, American Institute for Medical and Biological Engineering
Medical Device Design (2.750) - Fall 2019, Fall 2020, Spring 2022, Spring 2023, Spring 2024
Translational Engineering (2.S988) - Spring 2020, Spring 2021, Fall 2022, Fall 2024
Mechanics & Materials (2.001) - Fall 2021
Google Scholar: https://scholar.google.com/citations?hl=en&user=Htybq6sAAAAJ
NCBI My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/carlo.traverso.1/bibliography/public/